BioSpace News Archive

Accomplished leader with proven record of achievement to drive next phase of Company’s growth

Surface Plasmon Resonance is a phenomenon of squeezing light to a tiny volume, causing biomolecules to get trapped across a surface, which in turn enables their study under a microscope.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive Officer and President, and Mark Hahn, Chief Financial Officer, will present a company overview at the following virtual investor conferences in August 2020

OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that, further to the announcement made on Friday 31 July, the investor webinar, hosted by RedChip Companies, on Sunday, August 2, 2020 can be viewed at https://youtu.be/l8onUtOvSqQ.

IRLAB announced that the World Health Organization has proposed the name pirepemat as the International Nonproprietary Name for the company’s drug candidate IRL752, which is in development for decreasing the risk of falling in patients with Parkinson’s disease.

Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, reported its first quarter fiscal 2021 results and summarized recent key developments.

Cancer Transcriptome Atlas is the First in a Portfolio of GeoMx Products That Enable Spatial Genomics Using the Installed Base of Nearly 20,000 Next Gen Sequencers

Co-Diagnostics, Inc. announced that its partner, Clinical Reference Laboratory has received FDA Emergency Use Authorization for CRL Rapid Response™, a saliva-based COVID-19 test that can be self-administered at home, work or any other setting and then tested using Co-Diagnostics’ patented CoPrimer™ technology.

Microbiologics announced that it has recently completed renovations of the virology services laboratory in its San Diego location.

Zomedica Pharmaceuticals Corp., a veterinary health company, announced that Shameze Rampertab has resigned as Chief Financial Officer and member of the Board of Directors, effective August 14, 2020.